Epidemiological and Genetic Characterization of Coxsackievirus A6-Associated Hand, Foot, and Mouth Disease in Gwangju, South Korea, in 2022.
Ji-Eun LeeMin-Ji KimMi-Hyeon LimSue-Ji HanJin-Yeong KimSoo-Hoo KimYi-Duen HaGyung-Li GangYoon Seok ChungJung-Mi SeoPublished in: Viruses (2024)
Coxsackievirus A6 (CV-A6) has emerged as the predominant causative agent of hand, foot, and mouth disease (HFMD) in young children. Since the declaration of coronavirus disease 2019 (COVID-19) as a global pandemic, the incidence of infectious diseases, including HFMD, has decreased markedly. When social mitigation was relaxed during the COVID-19 pandemic in 2022, the re-emergence of HFMD was observed in Gwangju, South Korea, and seasonal characteristics of the disease appeared to have changed. To investigate the molecular characteristics of enterovirus (EV) associated with HFMD during 2022, 277 specimens were collected. Children aged younger than 5 years accounted for the majority of affected individuals. EV detection and genotyping were performed using real-time RT-PCR and nested RT-PCR followed by sequence analysis. The EV detection rate was found to be 82.3%, and the main genotype identified was CV-A6. Sixteen CV-A6 samples were selected for whole genome sequencing. According to phylogenetic analysis, all CV-A6 strains from this study belonged to the sub-genotype D3 clade based on VP1 sequences. Analysis of 3D polymerase phylogeny showed that only the recombinant RF-A group was identified. In conclusion, circulating EV types should be continuously monitored to understand pathogen emergence and evolution during the post-pandemic era.
Keyphrases
- coronavirus disease
- real time pcr
- infectious diseases
- sars cov
- respiratory syndrome coronavirus
- loop mediated isothermal amplification
- label free
- escherichia coli
- healthcare
- mental health
- climate change
- risk factors
- high throughput
- gene expression
- candida albicans
- dna methylation
- genetic diversity
- single molecule
- cell free